Home
FORMA Therapeutics

FORMA Therapeutics Market Share Analysis for May 2026

Forma Therapeutics is a clinical-stage biopharmaceutical company focused on therapeutics to transform the lives of patients with rare hematologic diseases and cancers.

Health > Biotechnology and Pharmaceuticals

Domainformatherapeutics.com

Year Founded2007

Employees51 - 200

Annual Revenue$100M - $200M

FORMA Therapeutics

FORMA Therapeutics (including company regionals)

formatherapeutics.com

See more website traffic and engagement information

FORMA Therapeutics Revenue up to May 2026 is 100M - 200M

revenue generated by FORMA Therapeutics top domains

FORMA Therapeutics top domains revenue over 3 years

Revenue for FORMA Therapeutics top domains

formatherapeutics.com100M - 200M

See more with Sales Intelligence

Total visits to FORMA Therapeutics's top domains

Understand FORMA Therapeutics market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in FORMA Therapeutics's top domains

Analyze FORMA Therapeutics engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on FORMA Therapeutics's top domains

See how FORMA Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

FORMA Therapeutics top competitors by domain

Top similar sites in May 2026, ranked by their affinity

sorrentotherapeutics.comCompany NameSorrento TherapeuticsEmployees501 - 1000HQUnited States, California, San DiegoAnnual revenue$50M - $75MTotal visits755Health > Biotechnology and Pharmaceuticals

Top technologies used by FORMA Therapeutics

These are the website technologies, by industry, used by FORMA Therapeutics top domains

Social (5)

Instagram

Widget (4)

Twemoji

Audio Video Media (3)

YouTube

Content Management System (3)

WordPress

More Technologies

8

See all

News & Signals from FORMA Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAspesi leaves FORMA Therapeutics, Inc. as Chief Human Resources Officer.Ms. Aspesi joins Editas from Forma Therapeutics, where she served as Chief Human Resources Officer and successfully led the negotiations related to the people elements of the US $1B acquisition of Forma by Novo Nordisk in late 2022.

NewsFORMA Therapeutics, Inc. launched Believe it! on Oct 23rd '22.Sickle Cell Disease Association of America and Forma Therapeutics, a biopharmaceutical company, recently launched Believe it!

NewsRigel Pharmaceuticals Inc. partnered with FORMA Therapeutics, Inc. on Aug 1st '22.In August, Rigel announced an exclusive license agreement with Forma Therapeutics, Inc. (Forma) to develop, manufacture and commercialize olutasidenib, an investigational, oral, small molecule inhibitor of mutant isocitrate dehydrogenase-1 (mIDH1) for the treatment of relapsed/refractory acute myeloid leukemia (R/R AML) and other malignancies.